Specifications
General Specifications
| # of assays: | 1 |
| Technology: | TaqMan® Assays - Pre-formulated assay (20x or 60x mix) |
| Scale: | Available in multiple scales |
| Intended Use: | Research Use Only |
Kit Storage
-20° C
Documents
Manuals & Protocols
Product Literature
- Brochure: TaqMan® Gene Expression Assays - A cumulative guide that covers our full line of TaqMan® Gene Expression Assay products and formats.
- Application Note: Amplification Efficiency of TaqMan® Gene Expression Assays
Citations & References (3)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
- Authors
- Gabert J et al.
- Journal
- Leukemia. 2003 Dec;17(12):2318-57.
Quantification of TELAML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia
- Authors
- SeÂverine Drunat et al.
- Journal
- British Journal of Haematology, 2001, 114, 281-289
Molecular Quantification of Response to Therapy and Remission Status in TEL-AML1-Positive Childhood ALL by Real-Time Reverse Transcription Polymerase Chain Reaction.
- Authors
- Karlheinz Seeger et al.
- Journal
- CANCER RESEARCH 61, 2517–2522, March 15, 2001.
